Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Company has issued $600,000,000 aggregate principal amount of 4.500% notes due February 20, 2031 in a public offering. The notes pay interest semi-annually on February 20 and August 20, starting August 20, 2026.
Before January 20, 2031, Eastman may redeem the notes at the greater of a make-whole amount based on the Treasury Rate plus 15 basis points or 100% of principal, plus accrued interest. On and after January 20, 2031, the notes are callable at 100% of principal, plus accrued interest.
The notes are senior unsecured obligations, ranking equally with other unsecured, unsubordinated Eastman debt and effectively junior to secured and subsidiary liabilities. If a change of control plus ratings downgrade occurs, holders can require Eastman to repurchase the notes at 101% of principal plus accrued interest. Net proceeds of approximately $593.7 million are earmarked for general corporate purposes, including working capital, capital expenditures, debt repayment and strategic initiatives.
Eastman Chemical Company executive Brad A. Lich, EVP & CCO, reported a tax-related share disposition on common stock. On February 18, 2026, 5,569 shares were withheld at $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023–2025 performance period. After this transaction, he directly owned 96,779 common shares, with additional indirect holdings through an ESOP and a 401(k) plan.
Eastman Chemical Company senior vice president Adrian James Holt reported a routine tax-withholding share disposition. On this Form 4, 588 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations from the payout of performance shares for the 2023-2025 performance period. After this non-market transaction, Holt directly holds 1,709 shares of Eastman Chemical common stock.
Eastman Chemical Company executive reports tax-related share withholding. EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith had 3,086 shares of common stock withheld at $80.26 per share on a tax-withholding disposition related to performance shares for the 2023–2025 performance period, leaving him with 24,235 directly owned shares.
Eastman Chemical Company senior vice president Julie A. McAlindon reported a tax-related share disposition involving company common stock. On February 18, 2026, 1,812 shares of common stock were withheld at $80.26 per share to satisfy tax obligations tied to a performance share payout for the 2023-2025 performance period.
After this withholding, McAlindon directly owned 18,199 shares of Eastman Chemical common stock. She also indirectly held 887 shares through an ESOP arrangement, reflecting separate plan-related ownership.
Eastman Chemical Company senior vice president Michelle H. Caveness had 528 shares of common stock withheld on February 18, 2026 to cover tax obligations tied to a performance share payout for the 2023–2025 period.
After this tax-withholding disposition, she directly owned 7,655 shares of Eastman Chemical common stock.
Eastman Chemical Company Controller and Chief Accounting Officer Michelle Renee Stewart reported a tax-related share disposition. On the reported date, 1,063 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023-2025 performance period. After this withholding, her directly owned common stock holdings were 7,209 shares.
Eastman Chemical executive vice president and CFO William Thomas McLain Jr. reported a tax-related share disposition involving company common stock. On the reported date, 4,471 shares were withheld at a price of $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023–2025 performance period. After this tax-withholding disposition, he directly held 65,313 shares of Eastman Chemical common stock.
Eastman Chemical CEO and board chair Mark J. Costa reported a tax-related share disposition. On the payout of performance shares for the 2023-2025 performance period, 25,260 shares of common stock were withheld to cover tax obligations at a price of $80.26 per share. After this withholding, Costa directly owns 497,929 shares of Eastman Chemical common stock, and indirectly holds 3,227 shares through an ESOP arrangement.
Eastman Chemical executive Stephen Glenn Crawford, EVP and Chief Technology and Sustainability Officer, had 4,720 shares of common stock withheld on February 18, 2026 at $80.26 per share to cover tax obligations from a 2023–2025 performance share payout. After this tax-withholding disposition, he holds 67,714 common shares directly, plus additional indirect holdings through 401(k) and ESOP accounts for himself and his spouse.